Annual report 2022 – Prostate cancer services during the COVID-19 pandemic (NPCA)
This 9th annual report from the National Prostate Cancer Audit (NPCA) covers the diagnostic period between 1 April 2020 and 31 March 2021, to bring clinicians and patients up to date with the prostate cancer landscape as it stood during the pandemic in England and Wales.
For England, it also covers the period up to the end of December 2021 and, for Wales, up to the end of March 2021, finding that the COVID-19 pandemic had a profound impact on the care provided to patients with cancer, with delays in prostate cancer diagnosis and treatment.
Between 1 April 2020 and 31 March 2021, the number of men diagnosed with prostate cancer in England and Wales was 32,426. This is a decrease on the number (45,885) reported in last year’s report, which covered the period 1 April 2019 to 31 March 2020. Other key findings for this period include:
- The number of men diagnosed with prostate cancer was 32,426, a decrease on the number (45,885) reported in last year’s report
- The proportion of men presenting with metastatic disease at diagnosis is 17%, an increase from 13% in last year’s report, and
- The proportion of men recorded as having an emergency readmission within 90 days of radical prostate cancer surgery is 12%, similar to the 13% reported last year.
Read the full report: You can see all key findings and read the report in full by clicking on the link below.
Stay-up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.